Growth of Consumer Out-of-Pocket Expenditures, 2018-2028 ($ Billion)

“Obesity, aging, and chronic conditions are demographic trends growing OOP expenditure.”

ARLINGTON, Va. (PRWEB)
July 25, 2023

Out-of-pocket expenditures (OOP) have long weighed upon the United States healthcare system and consumers. The weight is as heavy as ever in 2023 as OOP healthcare spending by consumers will reach an estimated $519 billion by year’s end, up almost 9% from 2022 with continued annual growth of 10% forecast through 2028. These findings are based on new data featured by leading medical market research firm Kalorama Information in the July 2023 report Out of Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition.

Kalorama Information reveals that over the next five years, total consumer out-of-pocket expenditures for healthcare are expected to continue rising, with trends established over the past several years continuing through the foreseeable future. While the COVID-19 pandemic of 2020 and 2021 caused a temporary pullback in consumer out-of-pocket healthcare spending, the historic trend resumed in 2022, initiating the current growth trajectory.

Multiple drivers are contributing to significant OOP spending growth. These include:

• 
  government, regulatory and insurance/payer actions, including Managed Care Organization cost shifting and numerous policy changes that make healthcare more expensive;
• business and economic trends, including actions taken by the business community and healthcare providers;
• high recent inflation, following increased government spending during the COVID-19 pandemic;
• pent-up demand for medical products and services during COVID-19 lockdown;
• social pressures related to rising standards of attractiveness;
• demographic trends that affect large groups of people such as obesity, aging and chronic conditions. Less common, yet expensive, demographic trends include mental illness and addiction.

Greater gains will be mitigated by continued rising usage of lower cost medications (generic drugs, OTC medicines, Rx-to-OTC switches), growing utilization of disease management programs and the proliferation of low premium, high deductible health plans. Furthermore, salary growth will continue to lag healthcare cost increases as well as residual inflation. As consumers are unable to afford rising expenditures, they will increasingly forgo treatment and/or search for less expensive options such as generic or OTC medications.

ABOUT THE REPORT

This report estimates U.S. consumer out-of-pocket spending on healthcare, particularly direct payments to providers and financed payments, for both elective and non-elective products and services. Excluded from forecasts are healthcare premiums paid to healthcare plan sponsors or employers.

For more information, or to purchase “Out of Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition,” please visit: https://kaloramainformation.com/product/out-of-pocket-spending-in-healthcare-6th-edition-pharmaceuticals-surgeries-tests-electives-premiums-copays-doctor-visits-other/.

ABOUT KALORAMA INFORMATION

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

Leonard Perlmutter (Ram Lev)
AMI Founder and Curriculum Developer

“More than 1 out of 2 physicians suffer from burnout today, and some specialties reach a burnout rate of 65%. This conference is a dire necessity!” – Leonard Perlmutter (Ram Lev), AMI Founder & Curriculum Developer

AVERILL PARK, N.Y. (PRWEB)
July 25, 2023

In the face of an alarming 53% burnout rate among the medical community, the American Meditation Institute (AMI) announced today that its proprietary training in Yoga Science as Holistic Mind/Body Medicine, which has now been proven by a peer reviewed clinical study to reduce burnout and stress, will be the centerpiece of the upcoming 12th annual Heart and Science of Yoga Conference October 17-21, 2023 at the Equinox Resort and Spa in Manchester, Vermont. This revolutionary, evidence-based antidote for burnout has been accredited by the American Medical Association (AMA) for 34 Continuing Medical Education credits (CMEs), and will be offered simultaneously in-person and virtually on Zoom.

Announcing a dramatic contribution toward the lowering of today’s unprecedented burnout rates and promoting holistic mind/body healing among the medical community, a clinical study published in the November 2022 issue of “Lifestyle Medicine” reported that the proprietary Yoga Science curriculum taught at the upcoming AMI physicians conference has been proven to reduce physician Burnout levels 23.3%, reduced Secondary Traumatic Stress levels 19.9%, and increased Compassion Satisfaction levels 11.2%.

According to curriculum developer and AMI founder Leonard Perlmutter, “The ‘Heart and Science of Yoga’ conference curriculum represents the oldest and most effective Holistic Mind/Body Medicine to relieve and prevent burnout, alleviate stress and inflammation, and rewardingly balance both work and home life.” Since establishing the American Meditation in 1996, Perlmutter has helped countless numbers of physicians and other healthcare providers reduce burnout and stress, and rediscover their love of medicine and life.

Upon completion of this conference, all participants will be able to: 1. Demonstrate knowledge of how Yoga Science as mind/body medicine can heal disease, manage addictive habits, alleviate stress, inflammation and physician burnout; 2. Develop equanimity, discrimination, will power, creativity and energy through a daily practice of AMI MEDITATION and diaphragmatic breathing; 3. Incorporate long-term strategies for healthy lifestyle choices using Yoga Psychology; 4. Demonstrate knowledge of the principles of both Ayurveda and Epigenetics; 5. Identify yogic practices to transform trauma and increase resilience; 6. Utilize Food as Medicine (diet and nutrition) to maximize personal wellbeing; 7. Demonstrate knowledge on the research and therapeutic modalities of yoga and meditation as mind/body medicine; 8. Recognize the physiological benefits of Easy-Gentle Yoga and to identify and disable chronic pain mechanisms for improved exercise, health and pain relief; 9. Help themselves and patients reduce conditioned habits of negative thinking and other symptoms of burnout through the healing powers of AMI MEDITATION and mantra science; 10. Use Chakra Psychology (subtle emotional/mental causes of stress) to diagnose and to better understand and treat dis-ease; 11. Recognize how AMI MEDITATION and meditation-in-action change the neural pathways in the brain to help manage pain; 12. Identify altered pathways in the brain due to addiction and the ability of Yoga Science and AMI MEDITATION to assist brain chemistry and circuitry to heal and rebuild itself; and, 13. Use the tools of Yoga Science to create a personal and medical culture of health and wellbeing.

The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive course for their students. Each faculty member is committed to the advancement and training of Yoga Science as Holistic Mind/Body Medicine. In addition to faculty director Leonard Perlmutter other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee; Jenness Cortez Perlmutter, faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; and Janine Pardo MD, board certified in Internal Medicine.

According to Kristin Kaelber MD PhD, Internist and Pediatrician, and returning alumna of the “Heart and Science of Yoga” conference, “This conference curriculum literally changed the direction of my career as a physician. The practical tools I’ve learned at the conference have enabled me to transform my work as a physician, helped me eliminate burnout, and enhanced my home life.”

-30-

About the American Meditation Institute

The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, AMI Meditation® and its allied disciplines as Mind/Body Medicine. In its holistic approach to wellness, AMI combines the healing arts, philosophy and spirituality of the East with the practicality of modern Western medical science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “Transformation” a bi-monthly journal of meditation as Holistic Mind/Body Medicine.

Call 518.674.8714 for interviews and a snail mail or email subscription.

Media Contact:

Robert Washington

PO Box 430

Averill Park, NY 12018

Tel: 518-674-8714

Fax: 518-674-8714

Share article on social media or email:

Pico IV

“Not only is it the merging of two really significant markets in the wellness industry, but it also represents how much potential there is when combining the power of science with one of nature’s greatest gifts.” said Joe Young, CEO and co-founder of Apex Labs CBD.

SACRAMENTO, Calif. (PRWEB)
July 25, 2023

Apex Labs CBD has developed a groundbreaking new product that combines the world CBD with intravenous (IV) therapy. By pioneering a new form of technology, the team at Apex Labs CBD was able to reduce the size of the CBD molecule to make it both water-soluble and small enough to pass through a sterile filter, making it safe for intravenous use. This first-of-its-kind sterile CBD solution can bring the many benefits of cannabidiol and the hemp world to IV Therapy Clinics across the country and complement a variety of functional or regenerative medicine offerings.

The intravenous (IV) hydration therapy market has experienced tremendous growth in the last decade and is projected to continue growing over the coming years. It offers a safe and easy way to deliver nutrients and hydration directly into the bloodstream. Some of the most popular IV therapy treatments target everything from skincare and hydration to hangover remedies and overall health and wellness. Pico IV offers the opportunity to supplement these treatments with the unique benefits of CBD, allowing IV Therapy to create custom protocols for their customers.

CBD, or cannabidiol, is one of the many non-psychoactive components naturally derived from the hemp plant. It interacts naturally with the body to support overall health and well-being. It can also help reduce occasional feelings of stress or anxiety, support a healthy sleep cycle, and potentially ease aches or pains due to overexertion.* Pico IV uses the CBD isolate with zero THC from industrial-grown hemp in the USA. Thanks to its legalization in 2018 with the Farm Bill, the CBD industry has been experiencing tremendous growth.

“We were incredibly excited to be able to bring this product to the market,” said Joe Young, CEO and co-founder of Apex Labs CBD. “Not only is it the merging of two really significant markets in the wellness industry, but it also represents how much potential there is when combining the power of science with one of nature’s greatest gifts. We’re proud to offer a new way for people to experience CBD.”

The desire for a CBD intravenous solution has been present for years, as other methods of CBD usage, like ingestion, topical or sublingual, don’t offer the same levels of system absorption as an IV solution. However, because the CBD molecule was too large to pass through a sterile filtration process, it would result in a non-sterile product. While recent developments in technology led to water-soluble CBD, and more recently, nanoemulsions, Miles Terry, (CSO, co-founder) created patent-pending technology that reduced the molecule size even further down to the size of a picometer, allowing for a sterile filtration process and maximum system absorptions.

Apex Labs CBD values quality and testing throughout the product development process. All products are sent to a third-party testing facility, California-Ag Labs, to test for potency and purity. The comprehensive test reports are published on the website and include test results for microbes, pesticides, metals, potency, mycotoxins, and residual solvents.

Robert Myer, owner of California Ag Labs, stated, “I am so thrilled for this development in the hemp world. I’m a long-time believer in the power of CBD and how it helps the body, naturally. To see this product realized is a dream come true. I believe it will open new doors for people to experience the benefits of CBD for themselves. And that’s what we want, to make the best quality CBD more accessible to everyone.”

Pico IV is currently available for purchase online after member registration. Each sterile vial has 50ml infused with approximately 200mg of CBD, or cannabidiol, and provides 4 doses at 50mg per dose. You must be a licensed IV therapy provider to purchase. For more information, visit PicoIV.com.

ABOUT APEX LABS CBD:

Founded in 2019, Apex Labs CBD began its mission to create top-quality CBD products on the market that are accessible to all. With a focus on product development, as well as rigorous testing and standards, the product offering grew to include everything from new cannabinoids to innovative product categories, like water-soluble tinctures and beverage enhancers. Apex Labs CBD offers both retail and B2B options, as well as a variety of resource services. With its expansion into the IV Therapy market, Apex Labs CBD will continue to operate with transparency, upholding high standards, all while creating new ways for people to experience the many benefits of CBD.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Share article on social media or email:

Penetrex

Penetrex® is the top joint and muscle relief cream for this sport and the official muscle and joint cream of the Professional Pickleball Association.

SAN RAFAEL, Calif. (PRWEB)
July 25, 2023

Penetrex®, an industry leader in joint and muscle relief, has become the main source of recovery for pickleball players experiencing injury from the game. Pickleball continues to be America’s fastest-growing sport, and, unfortunately, with it comes an increase in injuries costing nearly $400 million.

Penetrex® is the top joint and muscle relief cream for this sport and the official muscle and joint cream of the Professional Pickleball Association. A best-seller on Amazon with nearly 90,000 reviews, players turn to both these proprietary blends for whole-body support: Penetrex®Joint and Muscle Pain Relief Therapy Cream and Penetrex® Soothing Joint and Muscle Pain Relief Cream With Hemp and Menthol.

A renowned chemist in Southern California developed Penetrex®, and with over two million jars sold, it is a testament to its effectiveness.

“The surge in popularity of the court game has left thousands loving the game, but not the accompanying injuries,” said Lauren Pershing, Senior Brand Manager. “Penetrex® has been on the market for years for providing deep, fast-acting relief to joints and muscles. We now have found even more users after pickleball is getting attention for being a fun, competitive sport where injuries easily happen. The average age of pickleball players is 55. No one likes to be sidelined with an injury, especially at this age.”

PENETREX® soothing cream is a unique, non-greasy formulation without the burn, freeze or strong odor of other products. Apply PENETREX® to the back, neck, knees, hands, feet and other areas. It is recommended for use alone or with heating pads, ice packs, massagers and supplements. The natural ingredients, such as Arnica, Vitamin B6, MSM, Boswellia Serrata and Capsaicin, may help avoid surgery for some injuries.

For more information, visit http://www.penetrex.com.

About Penetrex®:

Penetrex is the most highly rated joint and muscle relief brand online, offering naturally inspired and effective solutions to joint and muscle discomfort. The brand’s flagship proprietary formula has been trusted by over 2 million people worldwide to provide fast and long-lasting relief. Penetrex is committed to improving the lives of those living with joint & muscle discomfort, allowing them to lead a more active and fulfilling life. Follow them on Instagram @penetrex.

Share article on social media or email:

Picis Logo

“Typically we engage with three or four face-to-face meetings during the sales cycle,” said Chris Lamont, Picis Vice President of Sales and Marketing. “But because of COVID restrictions, we had a half-day meeting in-person and ended up concluding the rest of the project remotely.”

WAKEFIELD, Mass. (PRWEB)
July 25, 2023

Picis, global developer of surgical management software, has announced the sale of their renowned perioperative suite to a large hospital on Long Island, New York.

It began as an opportunity to provide the Picis perioperative software suite to a customer who was losing support of theirs. However, there was more at stake. Time was of the essence.

The ultimate success of this venture demonstrated Picis’ understanding of changing market dynamics, their close working relationships with their partners, and their flexibility and resourcefulness with customers during the taxing circumstances of the COVID pandemic.

Bridging Gaps in Care

In early 2020, a major anesthesia device manufacturer announced they would no longer develop or support software for their popular perioperative suite in North America. Thus, they had a number of customers that would need a replacement solution.

Hospitals continue discovering the myriad benefits of electronic perioperative suites. These suites fully automate scheduling, pre-admission testing, pre-op on the day of surgery, nursing documentation, anesthesia documentation, PACU documentation and reporting – producing a single, contiguous patient record. One of the biggest benefits of Picis automation is that clinicians spend more time focused on patient care. And we have found that an automated solution also can potentially drive improved financial and operational results.

Chris Lamont, Picis Vice President of Sales and Marketing, sent his Long Island client a proposal for the Picis perioperative suite in March of 2020. And he knew this was not the only facility facing this circumstance. Because of the strong working relationship between partners, Lamont focused on all existing customers that were on this platform.

The Long Island client transformed its perioperative environment with Picis complete perioperative suite, including PreOp Manager, OR Manager, Anesthesia Manager, PACU Manager, and the SmarTrack Next patient tracking tool.

One of the reasons for choosing the Picis perioperative suite was how it interfaces seamlessly with hundreds of different devices. This eliminates the inconvenience of using third-party vendors to integrate devices, or the need to purchase expensive hardware add-ons.

Overcoming COVID Restrictions

All of this activity occurred amid the COVID lockdowns. “I didn’t have the opportunity to meet [the team at the Long Island hospital] in person before they signed this deal,” Lamont says. Based in Canada, he wasn’t able to cross the border. Undeterred, Picis sent Theresa Sullivan, their Director of Sales Operations, to fly up from Texas and demonstrate the perioperative suite.

Lamont goes on to say, “Typically we engage with three or four face-to-face meetings during the sales cycle. But because of COVID restrictions, we had a half-day meeting in-person and ended up concluding the rest of the project remotely.” To this day, Picis continues conducting much of its sales and product support remotely, saving clients and the company time and money, while still creating excellent relationships and delivering impactful results.

In this case and many others, marketplace intelligence, partner collaboration, ingenuity and an innovative product line have all helped Picis lead the industry while benefitting hospitals and patients alike.

About Picis

Picis is a global provider of clinical information solutions that automate the entire perioperative experience, from pre-op to anesthesia through PACU. They are a wholly owned subsidiary of N. Harris Computer Corporation, with licensed systems for use at more than 400 hospitals worldwide. For more information, contact Picis Clinical Solutions, 100 Quannapowitt Pkwy, Suite 405, Wakefield, MA 01880. Tel. +1 781 557 3000 or write info@picis.com

Share article on social media or email:

Karma Doctors & Associates is a rapidly growing psychiatry practice in Los Angeles and Palm Springs featuring innovative behavioral health services including transcranial magnetic stimulation (TMS).

“Proem gives us the tools we need to improve care for our patients and support our rapidly growing TMS service,” says Keerthy Sunder, MD, chief medical officer at Karma Doctors & Associates and medical director of Karma TMS.

ATLANTA (PRWEB)
July 25, 2023

Proem Behavioral Health, developer of the evidence-based clinical workflow software engine that helps efficiently and accurately screen, test and measure treatment success for those suffering from mental illness, is pleased to announce that it has been selected by Keerthy Sunder, MD, a distinguished, double-board certified psychiatrist, chief medical officer at Karma Doctors & Associates, and medical director of Karma TMS.

The rapidly growing psychiatry practice, with multiple locations in Los Angeles and Palm Springs, will use the Proem platform and its digitally licensed, structured and clinically validated assessment interviews to foster, promote and produce better outcomes for patients receiving transcranial magnetic stimulation (TMS).

An emerging, FDA-approved therapy for treatment-resistant depression and obsessive-compulsive disorder (OCD), success of TMS therapy is heavily reliant upon proper diagnosis and patient selection. Proem helps TMS providers by digging deeper into the most diagnosed DSM-5 conditions, including mood disorders and OCD.

Proem also assists TMS providers with utilization management. Insurance companies typically authorize and only pay for an initial number of TMS sessions, which may not be enough for a patient to achieve remission. With the Proem platform, providers can more effectively document patient progress and then use this data to support requests for extended treatment through additional sessions, giving patients the best possible chance at feeling better.

“Proem gives us the tools we need to improve care for our patients and support our rapidly growing TMS service,” says Dr. Sunder. “The platform enables us to more appropriately match our services with our patients’ needs by enhancing our ability to accurately identify their mental health disorders. In addition, Proem allows us to track clinical outcomes over time. This is powerful information we can show to our patients and payers to demonstrate treatment success, which increases patient engagement and opportunity for reimbursement.”

Proem’s exclusively licensed digital structured interviews have been validated to show psychiatrist agreement in 85% of diagnoses and been used in clinical settings, research studies and clinical trials for many years worldwide. The intelligent workflow engine from Proem captures and shares data at every step of the behavioral health care process, providing insight to help providers assess and diagnose mental illness and determine the next steps to take in a patient’s care. This leads to a significant result: improved outcomes for patients receiving mental illness treatment, including transcranial magnetic stimulation.

“As a leading psychiatrist and expert in the delivery of TMS, Dr. Sunder understands the importance of timely identification of behavioral health issues, accurate mental health data, and highly efficient processes that help patients who suffer from severe cases of depression and OCD,” said Proem CEO John Letter. “With Proem, TMS providers like Dr. Sunder and Karma TMS can better ensure proper patient selection, track and measure outcomes, engage patients in their care and prove outcomes to payers — all of which exemplify why we believe ‘healthier minds start with Proem.”

About Proem Behavioral Health

Proem Behavioral Health provides the premier clinical workflow software engine that helps behavioral health providers, substance use disorder clinics and research organizations efficiently and accurately screen, test and measure treatment success for those suffering from mental illness. Proem is the exclusive digital licensee worldwide of gold-standard, evidence-based screening solutions, structured interviews and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit proemhealth.com and follow Proem on LinkedIn and Twitter.

About Karma Docs

For more information about Dr. Keerthy Sunder and Karma Doctors & Associates, visit karmadocs.com.

Share article on social media or email:

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College.

This recognition focuses on the organization’s commitment to a caring culture in healthcare and academia.

NEWPORT BEACH, Calif. (PRWEB)
July 25, 2023

Unitek Learning is thrilled to announce that they have received special accolades from the Watson Caring Science Institute. On July 15, 2023, Unitek was awarded Lotus Recognition™ at the Caritas Community Conference in Boulder, Colorado. This recognition focuses on the organization’s commitment to a caring culture in healthcare and academia. It highlights industry leaders who have demonstrated their resolve to care for staff, students, healthcare partners, and systems.

“We are so thrilled to receive this recognition from the Watson Caring Science Institute,” said Janis Paulson, Chief Executive Officer at Unitek Learning. “WCSI is an international non-profit organization that advances Dr.Watson’s theories, philosophies, and practices of Caring Science. They work on a global level to instill excellence in caring for the patients and communities that we all serve. To be chosen by this organization is both an honor and a privilege.”

Dr. Jean Watson, PhD, RN, AHN-BC, FAAN, LL (AAN), nurse leader and pioneer of the Watson Caring Science Institute, added: “There is a difference between ordinary nursing and Caritas Nursing. The difference lies in the evolution of heart-centered consciousness and working from this evolved awareness. The first Caritas Process® of loving-kindness compassion and equanimity contributes to this evolution of a Caritas Nurse®.”

Unitek Learning has implemented various Caritas Praxis within academic programs and partnerships. The WCSI Lotus Recognition™ is focused on the three tenets of Watson’s Caring Science Theory and Praxis. Unitek has created healing environments, which include a leadership academy, Caritas Coach® leaders and centers of excellence for both students and faculty. In addition, Unitek has infused Watson Caring Science theory and Caritas language into their curriculum and advocates for resources to support human-to-human caring moments. By adopting the ethics of Watson Caring Science, Unitek Learning has transformed their educational model into one that promotes unique patient care and caring partnerships in academia. The goal is to sustain altruistic values by the practice of kindness, compassion, and equanimity with the self and others.

“As a leader in healthcare education, Unitek Learning’s vision is to co-create a healthier and more equitable world by repatterning the culture of nursing education and healthcare,” said Dr. Abdel Yosef, Provost and Chief Academic Officer at Unitek Learning. “We want to train and empower future nursing professionals to make a positive impact on their patients, their peers, and their communities. Our mission is to co-create a healing educational environment that contributes to the evolution of a ‘Caritas Nurse®.’ This type of nurse will change the world, and their world, one transpersonal caring moment at a time.”

About Unitek Learning: Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College. Unitek programs teach the clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in healthcare and nursing.

About Watson Caring Science Institute (WCSI): The Watson Caring Science Institute (WCSI) is an international non-profit organization that advances the philosophies, theories, and practices of Human Caring/Caring Science, founded by Jean Watson, Ph.D., RN, AHN-BC, FAAN, LL (AAN), WCSI’s Founder & Director. Focusing on research, education, praxis, leadership, and legacy, the institute aims to widen the development and understanding of Watson’s Caring Science to inform our notion of quality care and healing environments through various educational programs, partnerships, events and affiliations. For more information, please visit http://www.watsoncaringscience.org.

Share article on social media or email: